Journalism organizations offer data government blocked from public

Another development in the protest by three key journalism groups to the Obama administration’s decision to block public access to a public database of physician discipline and malpractice: Now, Investigative Reporters and Editors, working with the Association of Health Care Journalists and the Society of Professional Journalists, has posted the data for download, free to the public.

The data are posted for the entire U.S. in the original text format with documentation. IRE has also made available state-by-state Excel spreadsheet files.

On Thursday, the groups sent a letter protesting the decision to pull offline a the Public Use File of the National Practitioner Data Bank. The government has made this file available online for years, and reporters have used it to call attention to lax oversight of physicians across the country.

The public version of the database does not identify physicians by name or address, but it does provide other useful information about hospital sanctions, malpractice payouts and state disciplinary actions against every doctor in the country.

“We applaud IRE for making this data available for free to the media, researchers and the public,” said Charles Ornstein, AHCJ’s president. “While the government has decided that this ‘public use file’ should no longer be public, our organizations believe that it continues to be a critical resource. I encourage reporters, even those who have never used it before, to look for stories within it now.”

Journalists have used the data for years to draw attention to troubled physicians and state inaction. Recent examples include the St. Louis Post Dispatch, the Duluth (Minn) News-Tribune and The Kansas City Star. Other examples over the years have included The Hartford (Conn.) Courant and the Raleigh, N.C., News & Observer.

The U.S. Health Resources and Services Administration threatened a reporter from The Kansas City Star with financial penalties if he proceeded to write a story about a local neurosurgeon using information he gleaned from the public version of the database on the agency’s website. The newspaper published its story anyway on Sept. 4. The doctor’s attorney complained to the agency, prompting officials to remove the database from its website on Sept. 1.

Several news outlets - The New York Times, Los Angeles Times, Reuters and the St. Louis Post-Dispatch - are following the story.

AHCJ member publishes book on love, biochemistry

Feb. 21st, 2011 by Andrew Van Dam · Leave a Comment
Filed under: Uncategorized 

costelloAHCJ member Victoria Costello’s new book, “The Complete Idiot’s Guide to the Chemistry of Love,” is now on the market. Co-authored with evolutionary psychologist Maryanne Fisher, Ph.D., the book explores the “neuroscience of human emotions and relationships.”

For a quick introduction to the book’s subject matter and a frank discussion of how Costello has applied the principles of biochemistry in her own romantic relationship, head on over to her Psychology Today blog post. Costello has also made a preview available online.

Medi-Cal officials’ travel linked to drug makers

Mar. 1st, 2010 by Pia Christensen · Leave a Comment
Filed under: Uncategorized 

Records and interviews show that “Three California officials who oversee billions of dollars in Medi-Cal prescription drug spending have failed to disclose free flights, hotel rooms and meals paid for by nonprofit groups funded by drug makers,” according to Christina Jewett of California Watch.

One of the officials is directly involved in negotiating rebates with drug makers.

The nonprofits that paid for the trips are used to fund conferences and meetings and raise money by charging fees to drug company representatives who do business with Medicaid programs.

A Medi-Cal spokesman confirmed the trips and said they should have been reported as gifts. The agency has a policy against accepting gifts woth more than $320 from anyone that “has financial dealings with the department,” yet the spokesman said the agency had found no conflicts of interest in the trips.

ECRI reviews prostate cancer research

The ECRI Institute’s new review of recent research on the utility of off-label prescription of Finasteride in the prevention of prostate cancer (PDF) presents research and clinical guidelines. Its bibliography and research review may be useful for anyone considering a follow-up to Gina Kolata’s recent New York Times piece on cancer prevention. Finasteride blocks an enzyme that aids the proliferation of prostate cancer cells. It’s used to reduce the size of enlarged prostates and, under the name Propecia, to treat male pattern baldness.

A large trial on finasteride, known as the Prostate Cancer Prevention Trial (PCPT), was published in 2003. The 18,882 men (asymptomatic, with normal PSA levels, 55 years of age or older) enrolled in the trial were randomly assigned to receive either finasteride or placebo for 7 years. … The authors of the trial reported that finasteride reduced the incidence of prostate cancer from 24.4% to 18.4%; however, the incidence of high-grade prostate cancers was 25.6% higher in the finasteride group than the placebo group. The clinical significance of these findings is unclear and has been widely debated.

The impact of prophylactic finasteride on long-term mortality and quality of life was not reported by the PCPT. Two models forecasting the impact of finasteride on mortality in participants in the PCPT were published. Grover et al. predicted that for every 1,000 men treated with finasteride, a total of 20 life-years (0.02 years per individual) would be saved, and Lotan et al. predicted that men treated with finasteride would, on average, gain 1.7 months of life.

The ECRI release was prompted by Kolata’s piece in The New York Times which questions why drugs that have been proven to prevent cancer are not being taken while many potentially harmful (and useless) supplements are. Kolata mentioned the Finasteride case in addition to similar examples involving breast cancer prevention drugs.

According to its Web site, the nonprofit ECRI Institute “dedicates itself to bringing the discipline of applied scientific research to healthcare to discover which medical procedures, devices, drugs, and processes are best to enable improved patient care.” The acronym ECRI has been adopted as the organization’s full name, but used to stand for “Emergency Care Research Institute.”

Deadlines for health journalism awards released

Oct. 27th, 2009 by Pia Christensen · Leave a Comment
Filed under: Uncategorized 
Awards for Excellence in Health Car Journalism

Deadlines

Early-bird (discounted): Dec. 18

Regular: Jan. 22, 2010

Rules and entry form

AHCJ has opened its call for entries for the Awards for Excellence in Health Care Journalism, recognizing the best health reporting in print, broadcast and online media.

Last year’s winners included a reporter’s revelation of astonishing conflicts of interest by scientists advocating for early detection of lung cancer, the exploration of a hidden world of illegal prescription drugs sold at swap meets, a narrative on a mechanic seeking to rebuild his life after an accident severed his arms, and a trip into the nightmarish world of a boy struggling with mental illness.

Entries can include a wide range of health coverage including public health, consumer health, medical research, the business of health care and health ethics.

The contest was created by journalists for journalists and is not influenced or funded by commercial or special-interest groups.

Is Baucus’ excise on ‘Cadillac’ plans too broad?

Sep. 25th, 2009 by Andrew Van Dam · Leave a Comment
Filed under: Uncategorized 

The New York Times‘ Reed Abelson writes that the excise tax on premium health insurance plans that Montana Sen. Max Baucus is counting on to pay for about a quarter of his $774 billion reform proposal will hit urban families and union workers as hard as it will Goldman Sachs executives. Proportionally, in fact, union workers with less disposable income will suffer even more from the tax, which hits any plan that costs more than $8,000 for individuals or $21,000 for families, than high-flying white collar types.

The current national average for family policies is around $13,375, and only 1/10 of them would fall under the tax. But, Abelson reports, the pace of health premium inflation is such that far more policies will be caught in the tax net by the time the excise would go into effect in 2013.

The tax is based on the theory that it will help control health care costs by discouraging insurers from offering fancy plans that cover too many unnecessary tests and procedures. AHCJ immediate past president Trudy Lieberman writes for CJR.org that even this attempt to rein in costs will likely just increase them further as insurers pass the costs onto customers and the weaker coverage and corresponding rise in underinsurance forces folks faced with catastrophic conditions into financial difficulty or bankruptcy.

Blogger: Flu reporters got it right this time

Sep. 22nd, 2009 by Pia Christensen · Leave a Comment
Filed under: Uncategorized 

Bloggers at Effect Measure have some praise for “flu reporters” and their coverage of a recent NIH press release about the H1N1 vaccine in children.

The writer points out that the reporters he praises took the time to recognize that the real news was buried in the press release: that younger children will need two doses of the H1N1 vaccine.

The writer (the editors of Effect Measure sign their posts “Revere” to recognize Paul Revere, a member of the first local board of health in the United States) does call out one report for being just a rewrite of a press release but notes:

I’ve spent a lot of time here complaining how so much science reporting I see everyday is barely massaged press releases regurgitated by reporters acting as stenographers.

Pfizer tentatively tackles tweets

Jul. 27th, 2009 by Andrew Van Dam · Leave a Comment
Filed under: Uncategorized 

James Chase reports in Medical Marketing & Media that Pfizer has opened a Twitter account, @pfizer_news. The pharmaceutical behemoth will use the microblogging service for interacting and opening dialog with customers, rather than for product promotion or advertising, Chase reports. While Pfizer has been monitoring Twitter for months, executives were afraid to engage directly for fear that they would be “ripped to shreds” by the Twitterati.twitter_logo

“We’re trying to become transparent, but we’re doing it slowly and cautiously,” said (Ray Kerins, VP worldwide communications). “For us to jump in with two feet would be stupid. The first task was to get the communications team cleaned up because we’ve had a bad rap in that area.”

Pfizer hopes to increase its social media presence, but plans to do so cautiously and in gradual steps.

For now, Pfizer’s media relations team is charged with controlling all corporate tweeting, but Kerins said he hopes to expand the pool soon. “I would love to have by the end of the summer 100 people, from medical to public affairs, who have been anointed by the company and who can go out and Twitter.”

As of Monday morning (July 27), @Pfizer_News had gained 565 followers and was in turn following 225 users, many of them major media outlets.

Doc praises, explains benefits of electronic records

Jul. 22nd, 2009 by Andrew Van Dam · 1 Comment
Filed under: Uncategorized 

Calling the typical paper-based health record system “a primitive, fragmented and unreliable way to do business,” Rahul Parikh, M.D., writing for the Los Angeles Times, shows how electronic medical records have improved his practice.

Parikh’s piece starts from a foundation of a few electronic interactions with patients and builds a thesis from there:

In the past, these parents would have left a phone message and we probably would have spent the better part of a day or two playing phone tag. Or they would have had to make an appointment, strap their children into car seats, pack diaper bags and snacks and sit in a waiting room full of sick children — only to spend 5 to 10 minutes with me while I told them everything was fine. Instead, we fixed the issues by e-mail, allowing parents to stay in their lives at home and at work.

Parikh says that while EMRs do increase his workload – data entry is far more of a hassle than just scribbling something on a scrap of paper and shoving it into a file – they also allow him to shift between work and home when needed, giving his schedule a flexibility it lacked when he was permanently tied to the office by mountains of paper. While EMRs are “far from perfect,” he writes, they are still a significant improvement over the status quo.

Parikh acknowledges some criticisms of electronic medical records, such as a study that concluded using hand-held PDAs led to an increase in wrong and redudanct diagnoses. He says those errors can be remedied by “holding doctors and others accountable for the accuracy of their documentation.” As far as the security issues surrounding electronic records, he says they are legitimate concerns but no different from those in other industires, such as finance.

AHCJ resources

Past news about EMRs

Tip Sheet

Reports/Studies

On the Web

KING’s Duggan among Clarion Award winners

Jul. 15th, 2009 by Pia Christensen · Leave a Comment
Filed under: Uncategorized 

Pat Duggan, of KING-Seattle, has won a 2009 Association for Women in Communications Clarion Award for “Humoody,” an extended feature story that followed the struggles of a young Iraqi boy, left blinded and disfigured by gunfire, and the efforts of a Seattle surgical team to restore his face. Duggan also received a regional Emmy for the same piece.

The Clarion will be presented at the 2009 AWC National Conference in Seattle in October.

Next Page »